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Leukocyte telomere length (LTL) is ostensibly a biomarker of human aging. Cross-sectional analyses have found
that LTL is relatively short in a host of aging-related diseases. These studies have also provided indirect estimates
of age-dependent LTL shortening. In this paper, the authors report ﬁndings of the ﬁrst comprehensive longitudinal
study of 450 whites and 185 African Americans in Louisiana (aged 31.4 and 37.4 years at baseline (1995–1996)
and follow-up (2001–2006) examinations, respectively) participating in the Bogalusa Heart Study. Rate of change
in LTL was highly variable among individuals, with some displaying a paradoxical gain in LTL during the follow-up
period. The most striking observation was that age-dependent LTL shortening was proportional to LTL at baseline
examination. At both baseline and follow-up examinations, African Americans had longer LTLs than whites, and
smokers had shorter LTLs than nonsmokers. The longer LTL in African Americans than in whites explained in part
the faster rate of LTL shortening observed among African Americans. These ﬁndings underscore the complexity of
leukocyte telomere dynamics in vivo and suggest that determinants in addition to the ‘‘end-replication problem’’
contribute to telomere shortening in vivo.
aging; body mass index; leukocytes; oxidative stress; smoking; telomere
Abbreviations: BMI, body mass index; bp, base pairs; LTL, leukocyte telomere length.
Leukocyte telomere length (LTL) is highly variable at
birth (1, 2) and afterward (3–9). In cross-sectional analyses
based primarily on comparisons of LTL in individuals of
different ages, it seems that LTL progressively shortens lin-
early with age (3–9). However, cross-sectional analyses
hardly capture the rate and trajectory of age-dependent
LTL shortening in an individual, as well as variations in
these parameters among individuals. Deciphering patterns
of LTL shortening and variation in the rate of LTL shorten-
ing with age among individuals would be highly relevant
because shortened LTL has often been detected in individu-
als with aging-related disorders, cardiovascular disease in
particular (5, 9–12). Factors that predispose to cardiovascu-
lar disease, including obesity (4, 13, 14), insulin resistance
(8, 13), and cigarette smoking (4, 6, 14), are also associated
with shortened LTL. Moreover, a recent cross-sectional
analysisobservedthatLTLwaslonger,butitsage-dependent
shortening was faster, in adult African Americans than in
whites(15).Forthesereasons,weexaminedinalongitudinal
study the factors that contribute to variation in LTL shorten-
ing among young African-American and white adults in the
Bogalusa Heart Study (16). Our ﬁndings indicate that age-
dependent LTL shortening is proportional to LTL.
MATERIALS AND METHODS
Participants
The Bogalusa Heart Study is a long-term investigation of
the natural history of cardiovascular disease beginning in
childhood in the biracial community (65% white, 35%
African American) of Bogalusa, Louisiana (16). Between
1973 and 2006, 7 cross-sectional surveys of children aged
4–17 years and 9 cross-sectional surveys of adults aged
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dren, were conducted. In the ongoing Bogalusa Heart Study
cohort, 1,203 adults aged 24–44 years were examined for
cardiovascular risk factors between 2004 and 2006. LTL
data were available for 635 participants, who had blood
samples collected on 2 occasions—a baseline examination
in 1995–1996 and a follow-up examination in 2001–2006.
Compared with individuals not included, subjects with lon-
gitudinal LTL measurements showed no signiﬁcant differ-
ences in the relevant study variables, except that they were
0.8 years older (P ¼ 0.032). Self-administered question-
naires were used to obtain information on cigarette smok-
ing; those who smoked at least 1 cigarette per week during
the past 12 months were deﬁned as current smokers. The
study protocol was approved by the institutional review
board of Tulane University (New Orleans, Louisiana), and
each participant gave written informed consent.
LTL measurements
DNA from frozen blood samples, obtained at baseline and
follow-up examinations, was extracted by using the Gentra
Puregene Blood Kit (QIAGEN Inc., Valencia, California).
DNA integrity was assessed following electrophoresis of
0.02 lg of DNA (200 V for 0.75 hours) on 1% agarose gels
and staining with 2X SYBR Green I (Invitrogen Corpora-
tion, Carlsbad, California) for 45 minutes.
Telomere-length measurements were performed by ob-
tainingthemeanlengthoftheterminalrestrictionfragments,
using the Southern blot method, as previously described
(1, 13). In brief, after overnight DNA digestion with 10 U
Hinf I and 10 U Rsa I restriction enzymes (Roche Diagnos-
tics Corporation, Indianapolis, Indiana), samples of DNA
(3 lg each) were resolved on 0.5% agarose gels at 50 V
for 16 hours. DNA was then depurinated in 0.25 N hydro-
chloric acid, denatured in 0.5 mol/L of sodium hydroxide
per 1.5 mol/L of sodium chloride, and neutralized in
0.5 mol/L of tris(hydroxymethyl)aminomethane (pH 8)
per 1.5 mol/L of sodium chloride. After transfer to a posi-
tively charged nylon membrane, DNA was hybridized to
a digoxigenin 3#-end labeled 5#-(CCCTAA)3 telomeric
probe (overnight at 65 C), washed 3 times in 2X saline-
sodium citrate/0.1% of sodium dodecyl sulfate, and washed
once in 2X saline-sodium citrate. Probe was detected by the
digoxigenin luminescent detection procedure (Roche Diag-
nostics) after exposure on Hyperﬁlm (GE Healthcare, Chalfont
St. Giles, United Kingdom). Each sample was resolved in
duplicate on different gels, and autoradiograms were
digitized for analysis of telomere-length measurement.
Baseline and follow-up terminal restriction fragments
from the same individuals were resolved in adjacent lanes
of each gel, with samples run in duplicate on different gels.
The intraclass correlation coefﬁcient of LTL was 0.972 (P <
0.0001), and the coefﬁcient of variation for the duplicate
samples was 1.4%. The laboratory that conducted the LTL
measurements was blinded to the identity and characteris-
tics of subjects. The rate of change (loss or gain) in LTL was
computed as the difference between LTL value at follow-up
minus that at baseline examinations divided by the number
of years of follow-up.
Statistical analysis
Mean values and standard deviations were computed for
baseline and follow-up LTL and other continuous covariate
variables separately for African Americans and whites.
LTLs adjusted for age and body mass index (BMI) were
calculated as least-squares means for smokers and non-
smokers by holding age and/or BMI to their mean values.
Analysis of covariance was performed by using generalized
linear models to test differences in baseline and follow-up
LTL between African Americans and whites and between
smokers and nonsmokers. The relation between LTL attri-
tion and baseline LTL was examined by linear regression
models using rate of change in LTL as the dependent vari-
able, adjusting for race, age, sex, BMI, and smoking. Sta-
tistical analyses were performed by using SAS version 9.0
software (SAS Institute, Inc., Cary, North Carolina). Three
outliers (2 African-American women and 1 white man)
whose rate of LTL shortening was more than 250 base pairs
(bp)/year or LTL lengthening was more than 250 bp/year
were excluded from the analyses.
RESULTS
General characteristics
Major characteristics of the cohort are summarized in
Tables 1–3. The age ranges were 20.0–40.0 years at baseline
and 25.7–48.2 years at follow-up examinations. Smokers
constituted approximately a third of the cohort. African
Americans had a higher BMI than whites. Compared with
whites, African Americans had longer LTLs at baseline
and follow-up examinations and a higher rate of LTL short-
ening. The follow-up period was slightly shorter for African
Americans than for whites (5.7 years vs. 6.0 years), but this
difference was not signiﬁcant (P ¼ 0.1180). Table 2 sum-
marizes LTL parameters for smokers versus nonsmokers.
Age-, BMI-, and race-adjusted LTL was signiﬁcantly
shorter in smokers versus nonsmokers by 141 bp (P ¼
0.0227) at baseline examination and by 164 bp (P ¼
0.0099) at follow-up examination. However, we found no
signiﬁcant difference in the rate of LTL shortening between
smokers and nonsmokers.
We next examined the contribution of race, age, smoking,
BMI, and sex to variations in LTL at baseline and follow-up
examinations. Table 3 shows that race was the main factor
explaining variations in LTL at baseline and follow-up ex-
aminations and that smoking and BMI also accounted for
some of the variations.
Figure 1 displays the distribution of rate of change in LTL
among participants. This parameter varied considerably.
The majority of individuals displayed LTL shortening (loss)
(85.9% of African Americans and 88.0% of whites). In ad-
dition, 1 African American and 5 whites showed no change
in LTL between baseline and follow-up examinations. How-
ever, a subset of the cohort showed LTL gain. The means for
the rates of change for African Americans and whites are
displayed in Table 1. For the entire cohort, the mean rate of
change was  40.7 bp/year and was higher in African
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respectively; P ¼ 0.0181).
Given that different mechanisms are likely to govern LTL
shortening versus gain, we separately examined LTL dy-
namics in individuals who did not gain LTL during the
follow-up period. For these individuals (n ¼ 561), the
LTL shortening rate for African Americans was 60.0
(standard deviation, 47.6) bp/year and that for whites was
45.9 (standard deviation, 34.7) bp/year (P ¼ 0.0003).
Figure 2 displays the relation between the rate of LTL short-
ening that took place during the follow-up period and LTL
derived from the baseline samples. A strong association was
observed between the rate of LTL shortening and baseline
LTL (a 17-bp/year increase in the rate of LTL shortening for
each kilobase of LTL).
To evaluate the potential inﬂuence of measurement error
on the association of LTL and its rate of change, we set
a conservative limit of quantiﬁcation deﬁned as the absolute
value of the rate of change in LTL of less than 20 bp/year to
denote detectable change. The association between baseline
LTL and the rate of change was then examined for the sub-
group with smaller (<20 bp/year loss or gain, n ¼ 146) and
larger ( 20 bp/year loss or gain, n ¼ 489) changes in LTL.
For the smaller-change group, the association was not sig-
niﬁcant (b ¼  0.05, P ¼ 0.956), but, in the group with
a larger change, the regression coefﬁcient was signiﬁcant
(b ¼  13.7, P < 0.0001). This subgroup analysis provides
conﬁdence that measurement error did not play a signiﬁcant
role in the association noted in this study.
Since African Americans had longer LTL at baseline and
follow-up examinations and a higher rate of LTL shortening,
we examined the race effect and other pertinent factors on
the variations in LTL rate of change for the entire cohort and
separately for those individuals who demonstrated no gain
in LTL during the follow-up period. The ﬁndings are sum-
marized in Table 4. When considered alone, race signiﬁ-
cantly contributed to the variations in rate of change in
LTL. However, when race and LTL at baseline examination
Table 1. Major Characteristics of the Cohort of Young Adults in the Bogalusa Heart Study in












Age, years 31.4 (5.0) 31.4 (5.3) 31.4 (5.1) 0.7904
BMI, kg/m
2 27.1 (6.4) 30.5 (8.4) 28.1 (5.1) <0.0001
Smokers, % 32.4 36.8 33.7 0.2962
LTLB, bp 7,288 (735) 7,847 (734) 7,451 (777) <0.0001
Follow-up examination
Age, years 37.4 (4.4) 37.0 (4.7) 37.3 (4.5) 0.5823
BMI, kg/m
2 28.3 (6.6) 32.0 (8.9) 29.4 (7.5) <0.0001
Smokers, % 30.7 30.8 30.7 0.9715
LTLFU, bp 7,076 (721) 7,603 (767) 7,230 (772) <0.0001
Change in LTL
c
Follow-up, years 6.0 (2.4) 5.7 (2.5) 5.9 (2.4) 0.1180
LTL, bp/year  37.8 (41.3)  47.7 (55.3)  40.7 (46.0) 0.0181
Abbreviations: BMI, body mass index; bp, base pairs; LTL, leukocyte telomere length
(expressed in bp); LTLB, baseline LTL; LTLFU, follow-up LTL.
a Unless otherwise speciﬁed, data are presented as mean (standard deviation).
b P values for race difference in LTL and change in LTL were adjusted for age, sex, and BMI.
c Rate of change in LTL (bp/year) ¼ (LTLFU – LTLB)/follow-up years.
Table 2. Leukocyte Telomere Length Parameters of Interest in
Smokers Versus Nonsmokers Participating in the Bogalusa Heart
Study in Louisiana at Baseline (1995–1996) and Follow-up (2001–
2006) Examinations
LTL Parameter Nonsmokers Smokers P Value
Unadjusted LTL
LTLB, bp 7,481 7,392 0.0660
LTLFU, bp 7,270 7,150 0.0219
Age-adjusted LTL
LTLB, bp 7,492 7,370 0.0479
LTLFU, bp 7,275 7,128 0.0196
Age- and BMI-adjusted LTL
LTLB, bp 7,500 7,359 0.0227
LTLFU, bp 7,280 7,116 0.0099
Change, bp/year
a  40  42 0.4630
Abbreviations: BMI, body mass index; bp, base pairs; LTL, leuko-
cyte telomere length (expressed in bp); LTLB, baseline LTL; LTLFU,
follow-up LTL.
a Rate of change in LTL (bp/year) ¼ (LTLFU   LTLB)/follow-up
years.
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accounted signiﬁcantly for the rate of change in LTL, mean-
ing that the longer LTL in African Americans was a major
factor in the higher rate of LTL shortening in African
Americans versus whites. Adding age, BMI, smoking, and
sex at baseline examination to the model provided little
explanation above that of baseline LTL for interindividual
variation in LTL shortening rate. These observations held
when the data were analyzed for the entire cohort or after
exclusion of individuals who gained LTL between baseline
and follow-up examinations.
DISCUSSION
Our keyﬁnding in this biracial cohort of young adults was
that age-dependent LTL shortening rate was proportional to
LTL. In addition, we conﬁrmed previous observations in
a small sample of the Bogalusa Heart Study with a 10-year
follow-up showing that the rate of LTL shortening was
highly variable among individuals, with a subset of partic-
ipants displaying paradoxical lengthening of LTL during the
follow-up period (13). A previous cross-sectional analysis
of LTL in a combined sample of participants from the
Bogalusa Heart Study and the NHLBI Family Heart Study
(age range,19–93 years) found not only that LTL was longer
in African Americans than in whites but also that the rate of
age-dependent LTL shortening was faster in African
Americans (15). The present work indicates that the longer
LTL in African Americans partially explained their faster
age-dependent LTL shorteningcompared with thatof whites.
Cross-sectional analyses of leukocyte telomere dynamics
have suggested that age-dependent LTL shortening might be
slower (17, 18) or faster (19) in young than in older adults,
but these studies were statistically underpowered to test
either of these suppositions (20). Note that, in the present
study, cross-sectional analysis revealed only a small effect
of age on LTL attrition (Table 3), but this ﬁnding was due to
the considerable interindividual variation in LTL and the
relatively narrow age range of the cohort (20 years for
Figure 1. Distribution of the rate of change in leukocyte telomere
length (LTL) in Louisiana study participants. A total of 561 participants
showed LTL shortening, and 74 showed either gain (n ¼ 68) or no
change (n ¼ 6) in LTL between baseline (1995–1996) and follow-up
(2001–2006) examinations. bp, base pairs.
Figure 2. Relation between rate of leukocyte telomere length (LTL)
shortening during follow-up (2001–2006) and LTL derived from the
baselinesamples(1995–1996)inLouisianastudyparticipants.DLTL¼
0.017 baseline LTL – 0.073; r ¼ 0.326, P < 0.0001. bp, base pairs.
Table 3. Regression of Baseline (1995–1996) and Follow-up (2001–2006) Leukocyte Telomere Length on
Parameters of Interest for Participants in the Bogalusa Heart Study in Louisiana
a
Parameter
Baseline LTL Follow-up LTL
b Coefﬁcient P Value Partial R
2 Model R
2 b Coefﬁcient P Value Partial R
2 Model R
2
Race, African American 587.8 <0.0001 0.107 551.5 <0.0001 0.096
Age, years  13.4 0.0220 0.009  11.7 0.0715 0.005
BMI, kg/m
2  9.1 0.0316 0.006  8.6 0.0312 0.007
Smoking, yes/no  141.6 0.0227 0.006  163.5 0.0099 0.008
Sex, female 56.8 0.3456 0.002 0.130 37.0 0.5372 0.000 0.116
Abbreviations: BMI, body mass index; LTL, leukocyte telomere length (expressed in base pairs (bp)).
a The rate of change in LTL (bp/year) is negative; therefore, negative regression coefﬁcients denote faster LTL
attrition.
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examinations) (20).
What, then, might be the reason for the dependency of
leukocyte telomere shortening on LTL itself? In cultured
somatic cells, telomeres become shortened with cell divi-
sion. The same apparently holds for somatic cells in vivo,
given that telomere length is substantially longer in skeletal
muscle, a postmitotic tissue, than in proliferative tissues (21).
The inability of DNA polymerase to replicate nuclear DNA
to its terminus—the so-called end-replication problem—
would result in telomere shortening with somatic cell di-
vision (22, 23), a process that is autonomous of telomere
length. However, both theoretical considerations and empir-
ical data suggest that the ‘‘end-replication problem’’ ac-
counts for only a fraction of telomere shortening with
replication (24–26).
Telomere length is variable not only among different
chromosomes (27) but also between homologous chromo-
somes (28), and it shortens faster in the homologous chro-
mosome with the longer telomeres. This ﬁnding suggests
that telomere shortening might depend on telomere length.
Telomere shortening that is dependent on telomere length
would maintain the length proportionality among different
telomeres. In contrast, replication-mediated clipping of
a ﬁxed stretch of telomere repeats from telomeres of differ-
ent lengths would result in loss of proportionality between
telomere length in a single chromosome and the mean telo-
mere length of all chromosomes. This possibility does not
seem to be the case; proportionality between the length of
telomeres in single chromosomes and the mean length of
telomeres in all chromosomes is maintained not only in
sperm (29) but also in somatic cells such as leukocytes from
donors of a wide age range (30). The factor that might cause
proportional telomere shortening is oxidative stress (31–34)
because longer telomeres are bigger targets for free radicals,
which attack the G triplets on the telomeres.
The following 2 suppositions are at the heart of studies
exploring the use of LTL as a biomarker of human aging:
1) oxidative stress and inﬂammation are key elements in the
biology of aging and in aging-related disorders (35, 36); and
2) leukocytetelomere dynamics register the accruingburden
of oxidative stress and inﬂammation over the life course of
the individual (reviewed by Aviv (37)). Thus, the shortened
LTL displayed by individuals who suffer from aging-related
diseases presumably results from an accelerated rate of age-
dependent LTL shortening. This presumption is based on
ﬁndings that oxidative stress augments telomere attrition
per replication (31–34) and the inﬂammation heightens the
turnover of leukocytes, which would further increase LTL
shortening with age. Such a concept supports the tenet that
the shortened LTL in persons with atherosclerotic cardio-
vascular disease (5, 9–12) is due to a protracted increase in
the inﬂammatory and oxidative stress burdens (38, 39).
The ﬁndings of the present study support previous obser-
vations that LTL was shorter in smokers than in nonsmokers
(4, 6, 14) and was inversely correlated with BMI (4, 9,
13–15), presumably because smoking and obesity are asso-
ciated with accelerated LTL shortening. However, as shown
in Table 2, we could not demonstrate a statistically signiﬁ-
cant difference in the rate of LTL shortening for smokers
versus nonsmokers. One potential explanation might be that
our method was insufﬁciently sensitive to detect differences
in the rates of LTL shortening between smokers and non-
smokers, although the gap in LTL between the 2 groups did
increase with age. Theoretically, LTL might be rapidly
shortened after an individual starts smoking. Such rapid
shortening would attenuate the rate of shortening thereafter
because of the proportionality of LTL loss to LTL itself.
Table4. Regressionof the Rateof Changein LeukocyteTelomere Lengthon Parameters of Interest for Participants in the BogalusaHeart Study
in Louisiana
a,b
Entire Cohort (n 5 635) Subjects With no Gain in LTL (n 5 561)
b Coefﬁcient P Value Partial R
2 Model R




Race, African American  9.9 0.0135 0.010 0.010  14.1 <0.0001 0.026 0.026
Model II
Race, African American  4.6 0.2772 0.010  5.9 0.1070 0.026
LTLB,b p  9.6 <0.0001 0.023 0.033  15.6 <0.0001 0.084 0.110
Model III
Race, African American  3.4 0.4309 0.010  4.4 0.2424 0.026
LTLB,b p  9.9 <0.0001 0.023  16.1 <0.0001 0.084
Age, years  0.6 0.1120 0.003  0.6 0.0605  0.007
BMI, kg/m
2  0.2 0.5464 0.000  0.3 0.1288 0.004
Smoking, yes/no  3.6 0.3533 0.000  0.5 0.8760 0.000
Sex, female  3.6 0.3378 0.002 0.038  1.3 0.6885 0.000 0.121
Abbreviations: BMI, body mass index; bp, base pairs; LTL, leukocyte telomere length (expressed in bp); LTLB, baseline LTL; LTLFU, follow-up
LTL.
a The rate of change in LTL (bp/year) ¼ (LTLFU   LTLB)/follow-up years.
b The rate of change in LTL is negative; therefore, negative regression coefﬁcients denote faster LTL attrition.
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as to the reason for the gain in LTL in a small subset of the
cohort. We doubt that it relates to technical matters. Age-
dependent LTL shortening would largely mirror telomere
attrition in hematopoietic stem cells and progenitor cells,
assuming that telomere shortening downstream of hemato-
poietic stem cells/progenitor cells is relatively constant.
However, this constancy might not hold all the time. For
instance,acuteinfectionmighttransientlyincreaseprolifera-
tion of peripheral mononuclear cells, resulting in a tempo-
rary increase in the difference between LTL and telomere
length in hematopoietic stem cells/progenitor cells. This
transient effect would not shorten by much telomere length
in hematopoietic stem cells/progenitor cells over the life
course of the individual, but it might affect LTL results in
a longitudinal study of short duration. Another alternative
relates to the status of hematopoietic stem cells within bone
marrow niches. Evidently, hematopoietic stem cells residing
in the osteoblastic niche are largely quiescent; their mobi-
lization into the vascular niche, which might arise from
a host of factors, promotes their transformation into prolif-
erative hematopoietic stem cells (40). It might be possible
that, in a small subset of participants, a crop of quiescent
hematopoietic stem cells were mobilized into the vascular
niche between baseline and follow-up examinations, reset-
ting LTL above its length at the baseline examination. Both
of these possibilities, if present, would not only account for
LTL gain but also contribute to variation in LTL shortening
during the follow-up period.
The dependence of LTL shortening on LTL suggests that
the rate of LTL shortening declines in older individuals.
However, the factors that affect LTL dynamics in the in-
dividual are anything but constant throughout adulthood
because the precursors of inﬂammation and oxidative stress
progressively increase with age (41–43). Individually or
jointly, inﬂammation and oxidative stress might therefore
sustain or even accelerate the rate of LTL shortening in
the elderly, even though LTL progressively shortens with
age. Accordingly, only longitudinal evaluations of LTL
shortening rates in different age groups and diverse sample
populations would provide a reliable appraisal of leukocyte
telomere dynamics as humans get older.
Regarding potential regression to the mean effect, base-
line telomere length was not relevant to the inclusion of
subjects in the study. In terms of average change, any mask-
ing effect of LTL dynamics was not an issue because strong
biologic arguments support LTL shortening with age. The
potential latent effect of race may underlie some of our
results, but race was independent of inclusionary criteria
in the study and was used to further stratify the analysis.
In terms ofinduced correlation between baseline and change
from baseline, age adjustment of only those changes from
baseline, as well as the existing high level of variation in
LTL at baseline and changes from baseline, limited this
effect. The use of analysis of covariance also limited un-
foreseen regression to the mean effects.
In conclusion, this comprehensive longitudinal study of
age-dependent LTL shortening underscores the complexity
of leukocytetelomere dynamics. Its ﬁndings support the role
of mechanisms additional to the end-replication problem in
telomere dynamics in vivo and explain in part the faster rate
of LTL shortening in African Americans than in whites. LTL
itselfaccountsforapproximately10%ofthevariationinLTL
shortening, meaning that a host of other factors inﬂuence
leukocyte telomere dynamics in both African Americans
and whites. However, the effect of LTL on itsown shortening
rate is sizable and requires careful consideration in longitu-
dinal studies that examine leukocyte telomere dynamics.
Such studies might provide valuable information about the
biology of human aging.
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